Regulation of adult erythropoiesis by prolyl hydroxylase domain proteins
Open accessThe DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Abstract
Polycythemia is often associated with erythropoietin (EPO) overexpression and defective oxygen sensing. In normal cells, intracellular oxygen concentrations are directly sensed by prolyl hydroxylase domain (PHD)-containing proteins, which tag hypoxia-inducible factor (HIF) alpha subunits for polyubiquitination and proteasomal degradation by oxygen-dependent prolyl hydroxylation. Here we show that different PHD isoforms differentially regulate HIF-alpha stability in the adult liver and kidney and suppress Epo expression and erythropoiesis through distinct mechanisms. Although Phd1(-/-) or Phd3(-/-) mice had no apparent defects, double knockout of Phd1 and Phd3 led to moderate erythrocytosis. HIF-2alpha, which is known to activate Epo expression, accumulated in the liver. In adult mice deficient for PHD2, the prototypic Epo transcriptional activator HIF-1alpha accumulated in both the kidney and liver. Elevated HIF-1alpha levels were associated with dramatically increased concentrations of both Epo mRNA in the kidney and Epo protein in the serum, which led to severe erythrocytosis. In contrast, heterozygous mutation of Phd2 had no detectable effects on blood homeostasis. These findings suggest that PHD1/3 double deficiency leads to erythrocytosis partly by activating the hepatic HIF-2alpha/Epo pathway, whereas PHD2 deficiency leads to erythrocytosis by activating the renal Epo pathway.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Of the three PHD family members, PHD2 (also called EglN1) appears to be the primary HIF prolyl hydroxylase, contributing the majority of HIF prolyl hydroxylase activity in normoxic cells and hence setting normoxic HIF1α levels (Berra et al., 2003; Minamishima et al., 2008; Takeda et al., 2008).”
From Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. (2008) · cites this paper as Takeda et al., 2008
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“This is in contrast to the kidney where inactivation of PHD2 alone is sufficient to produce severe erythrocytosis.”
From Regulation of erythropoiesis by hypoxia-inducible factors (2013) · cites this paper as [240]
In the citing paper
“Furthermore, PHD1 and PHD3 appear to preferentially target HIF-2α in vitro and in vivo”
From Regulation of erythropoiesis by hypoxia-inducible factors (2013) · cites this paper as [240]
In the citing paper
“Inducible, global deletion of PHD2 in adult mice resulted in severe erythrocytosis from a dramatic increase in renal EPO production (Hct values > 80%), as well as other organ pathologies, in particular when PHD3 was inactivated simultaneously.”
From Regulation of erythropoiesis by hypoxia-inducible factors (2013) · cites this paper as [240]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Targeting HIF-1 for cancer therapy
Semenza, G. L. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1187 · Cited by 6,717
Jaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735
Epstein, A. C. R., Gleadle, J. M., McNeill, L. A., Hewitson, K. S., O'Rourke, J., Mole, D. R., Mukherji, M., Metzen, E., Wilson, M. I., Dhanda, A., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00507-4 · Cited by 3,333
Purification and Characterization of Mouse Hematopoietic Stem Cells
Spangrude, G. J., Heimfeld, S., & Weissman, I. L. (1988) · Science · doi:10.1126/science.2898810 · Cited by 2,824
A conserved family of prolyl-4-hydroxylases that modify HIF
Bruick, R. K., & McKnight, S. L. (2001) · Science · doi:10.1126/science.1066373 · Cited by 2,549
Purification and Characterization of Hypoxia-inducible Factor 1
Wang, G. L., & Semenza, G. L. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.3.1230 · Cited by 2,073
Berra, E., Benizri, E., Ginouvès, A., Volmat, V., Roux, D., & Pouysségur, J. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg392 · Cited by 1,348
Morrison, S. J., & Weissman, I. L. (1994) · Immunity · doi:10.1016/1074-7613(94)90037-x · Cited by 1,115
Cited by
Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway.
Kaelin, W. G., & Ratcliffe, P. J. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.04.009 · Cited by 3,251
“Interestingly, the pattern of activation of HIFa and the erythropoietic growth factor EPO in these animals differs from that associated with PHD2 / inactivation, involving HIF2a activation and EPO expression in the liver, as opposed to the kidney (Takeda et al., 2008).”
BackgroundMazzone, M., Dettori, D., Leite de Oliveira, R., Loges, S., Schmidt, T., Jonckx, B., Tian, Y.-M., Lanahan, A. A., Pollard, P., Ruiz de Almodovar, C., et al. (2009) · Cell · doi:10.1016/j.cell.2009.01.020 · Cited by 812
“In another study, inducible broad-spectrum inactivation of PHD2 after birth (PHD2 IND-KO ) induced growth of supernumerary vessels in healthy organs (Takeda et al., 2008; Takeda et al., 2007).”
Regulation of erythropoiesis by hypoxia-inducible factors
Haase, V. H. (2013) · Blood Reviews · doi:10.1016/j.blre.2012.12.003 · Cited by 787
“Furthermore, PHD1 and PHD3 appear to preferentially target HIF-2α in vitro and in vivo, which offers potential for therapeutic exploitation under conditions in which HIF-1 activation is non-desirable.(239,242) Aside from stimulating endogenous EPO synthesis, pharmacological”
BackgroundThe von Hippel–Lindau tumour suppressor protein: O2 sensing and cancer
Kaelin Jr, W. G. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2502 · Cited by 726
“Conditional inactivation of PHD2 in mice leads to polycythaemia owing to HIF stabilization and increased transcription of HIF-responsive erythropoietic genes such as erythropoietin”
BackgroundAdam, J., Hatipoglu, E., O'Flaherty, L., Ternette, N., Sahgal, N., Lockstone, H., Baban, D., Nye, E., Stamp, G. W., Wolhuter, K., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.09.006 · Cited by 585
“Mice lacking both Phd1 and -3 are viable and develop mild erythrocytosis, although levels of Hif-1a or Hif-2a in the kidney remain normal (Takeda et al., 2008), whereas deletion of Phd2 results in an embryonic lethal phenotype (Takeda et al.”
Metadata
- Authors
- Takeda, K., Aguila, H. L., Parikh, N. S., Li, X., Lamothe, K., Duan, L.-J., Takeda, H., Lee, F. S., & Fong, G.-H.
- Affiliations
- UConn Health (US)
- Connecticut Children's Medical Center (US)
- University of Pennsylvania (US)
- Center for Vascular Biology, Department of Cell Biology,
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2008-03-15
- Volume
- 111
- Issue
- 6
- Pages
- 3229-3235
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- PMC
- PMC2265459
- OpenAlex
- W2030334534
- Cited by
- 263
- References
- 53
- Citations by year
- 2026: 4 · 2025: 8 · 2024: 6 · 2023: 7 · 2022: 7 · 2021: 6 · 2020: 8 · 2019: 15 · 2018: 8 · 2017: 11 · 2016: 21 · 2015: 22 · 2014: 16 · 2013: 21 · 2012: 16
- FWCI
- 14.34
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Blood (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Heart Association
- National Institutes of Health
- U.S. Public Health Service (R01 C090261)
- National Heart, Lung, and Blood Institute (5P01HL70694, P01HL070694)
- National Cancer Institute (R01CA090261)
- Topics
- Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Hemoglobin structure and function
- Keywords
- erythropoietin, hypoxia-inducible factor alpha, HIF-1α, HIF-2α, erythrocytosis, polycythemia, oxygen sensing, PHD2, PHD1, PHD3, liver, kidney
- MeSH terms
- Aging, Animals, DNA-Binding Proteins, Erythropoiesis, Hematopoietic Stem Cells, Procollagen-Proline Dioxygenase, Immediate-Early Proteins, Mice, Knockout, Mice, Hypoxia-Inducible Factor-Proline Dioxygenases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Regulation of adult erythropoiesis by prolyl hydroxylase domain proteins. https://app.cochat.ai/papers/10.1182/blood-2007-09-114561
- The paper
- Takeda, K., Aguila, H. L., Parikh, N. S., Li, X., Lamothe, K., Duan, L.-J., Takeda, H., Lee, F. S., & Fong, G.-H. (2008). Regulation of adult erythropoiesis by prolyl hydroxylase domain proteins. Blood. https://doi.org/10.1182/blood-2007-09-114561
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.